You are here

BASF

BASF launches Hepaxa as first dedicated product in the U.S. to help patients manage Non-Alcoholic Fatty Liver Disease

CP Wire

Fri, 02/23/18 - 07:51 am

non-alcoholic fatty liver disease

Release: BASF launches Hepaxa as first dedicated product in the U.S. to help patients manage Non-Alcoholic Fatty Liver Disease

Fri, 02/23/18 - 12:28 am

non-alcoholic fatty liver disease

Catalent pairs with BASF on biovailability challenges

NJ Biz, NJ

Sat, 04/14/12 - 12:58 pm